Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature
Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature have?
Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature has 30 citations in the OpenAlex counts ScholarIQ stores.
When was Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature published?
Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature has 2017 year in the ScholarIQ index.
What is the open-access status of Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature?
Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature has gold oa status in the ScholarIQ index.
What is the DOI of Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature?
The DOI for Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature is on the source record.
What is the PMID of Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature?
The PMID for Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature is on the source record.
What is the OpenAlex record for Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature?
The OpenAlex for Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature is on the source record.